The persistent activation of inflammatory signaling pathways, including NF-κB and JNK, interferes with insulin receptor signaling in adipocytes and skeletal muscle cells, reducing insulin sensitivity and promoting hyperglycemia. The gene discussed is INS; the disease is Hyperglycemia.